Camurati-Engelmann disease

Changed by Tim Luijkx, 24 Feb 2015

Updates to Article Attributes

Body was changed:

Camurati-Engelmann disease (CED), also known as progressive diaphyseal dysplasia (PDD),is a rare autosomal dominant sclerosing bony dysplasia. It begins in childhood and follows a progressive course. 

Clinical presentation

Common symptoms include extremity pain, muscle weakness, cranial nerve impairment and waddling gait. A small proportion can be asymptomatic.Patients Patients can have hepatosplenomegaly 5.

Pathology

In a vast majority of cases it occurs from a defect in the TGFB1 gene.

Distribution

Tends to be bilateral and symmetrical. Can affect any bone but has a greater predilection for the long bones (femur, tibia, fibula, humerus, ulna and radius). Other common sites include the skull and pelvis.

Radiographic features

Plain film
  • there is fusiform bony enlargement with sclerosis in long bones 6
  • the epiphyses are spared
Bone scintigraphy
  • affected regions show high uptake with Tc99 MDP-MDP bone scintigraphy representing osteoblastic activity 4

Historical context

Named after 2, 3:

  •  M Camurati, Italian physician
  • G Engelmann, German physician

Treatment and prognosis

Complications

History and etymology

Named after 2, 3:

  • M Camurati, Italian physician
  • G Engelmann, German physician

Differential diagnosis

General imaging differential considerations include

  • -<p><strong>Camurati-Engelmann disease (CED)</strong>, also known as <strong>progressive diaphyseal dysplasia (PDD)</strong>,<strong> </strong>is a rare autosomal dominant <a href="/articles/sclerosing-bone-dysplasias">sclerosing bony dysplasia</a>. It begins in childhood and follows a progressive course. </p><h4>Clinical presentation</h4><p>Common symptoms include extremity pain, muscle weakness, cranial nerve impairment and waddling gait. A small proportion can be asymptomatic. <span style="line-height:1.6em">Patients can have hepatosplenomegaly </span><sup style="line-height:1.6em">5</sup><span style="line-height:1.6em">.</span></p><h4>Pathology</h4><p>In a vast majority of cases it occurs from a defect in the TGFB1 gene.</p><h5>Distribution</h5><p>Tends to be bilateral and symmetrical. Can affect any bone but has a greater predilection for the long bones (femur, tibia, fibula, humerus, ulna and radius). Other common sites include the skull and pelvis.</p><h4>Radiographic features</h4><h5>Plain film</h5><ul>
  • +<p><strong>Camurati-Engelmann disease (CED)</strong>, also known as <strong>progressive diaphyseal dysplasia (PDD)</strong>,<strong> </strong>is a rare autosomal dominant <a href="/articles/sclerosing-bone-dysplasias">sclerosing bony dysplasia</a>. It begins in childhood and follows a progressive course. </p><h4>Clinical presentation</h4><p>Common symptoms include extremity pain, muscle weakness, cranial nerve impairment and waddling gait. A small proportion can be asymptomatic. Patients can have hepatosplenomegaly <sup>5</sup>.</p><h4>Pathology</h4><p>In a vast majority of cases it occurs from a defect in the TGFB1 gene.</p><h5>Distribution</h5><p>Tends to be bilateral and symmetrical. Can affect any bone but has a greater predilection for the long bones (femur, tibia, fibula, humerus, ulna and radius). Other common sites include the skull and pelvis.</p><h4>Radiographic features</h4><h5>Plain film</h5><ul>
  • -</ul><h5>Bone scintigraphy</h5><ul><li>affected regions show high uptake with <strong>Tc</strong><sup>99</sup> MDP bone scintigraphy representing osteoblastic activity <sup>4</sup>
  • -</li></ul><h4>Historical context</h4><p>Named after <sup>2, 3</sup>:</p><ul>
  • -<li> M Camurati, Italian physician</li>
  • -<li>G Engelmann, German physician</li>
  • -</ul><h4>Treatment and prognosis</h4><h5>Complications</h5><ul><li>progressive stenosis of the <a href="/articles/optic-canal">optic canals</a> and compressive <a href="/articles/optic-neuropathy">optic neuropathy</a> can give <a href="/articles/papilloedema">papilloedema</a> <sup>7</sup>
  • -</li></ul><h4>Differential diagnosis</h4><p>General imaging differential considerations include</p><ul>
  • +</ul><h5>Bone scintigraphy</h5><ul><li>affected regions show high uptake with Tc<sup>99</sup>-MDP bone scintigraphy representing osteoblastic activity <sup>4</sup>
  • +</li></ul><h4>Treatment and prognosis</h4><h5>Complications</h5><ul><li>progressive stenosis of the <a href="/articles/optic-canal">optic canals</a> and compressive <a href="/articles/optic-neuropathy">optic neuropathy</a> can give <a href="/articles/papilloedema">papilloedema</a> <sup>7</sup>
  • +</li></ul><h4>History and etymology</h4><p>Named after <sup>2, 3</sup>:</p><ul>
  • -<a href="/articles/van-buchem-disease">van Buchem disease </a>:</li>
  • +<strong>M Camurati</strong>, Italian physician</li>
  • -<a href="/articles/osteopetrosis">osteopetrosis </a>:</li>
  • +<strong>G Engelmann</strong>, German physician</li>
  • +</ul><h4>Differential diagnosis</h4><p>General imaging differential considerations include</p><ul>
  • -<a href="/articles/ribbing-disease">Ribbing disease </a>(<a href="/articles/multiple-diaphyseal-sclerosis">multiple diaphyseal sclerosis</a> : can appear similar but presents in middle age <sup>1 </sup>
  • +<a href="/articles/van-buchem-disease">van Buchem disease</a>:</li>
  • +<li>
  • +<a href="/articles/osteopetrosis">osteopetrosis</a>:</li>
  • +<li>
  • +<a href="/articles/ribbing-disease">Ribbing disease </a>(<a href="/articles/multiple-diaphyseal-sclerosis">multiple diaphyseal sclerosis</a>): can appear similar but presents in middle age <sup>1 </sup>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.